Please ensure Javascript is enabled for purposes of website accessibility

Health Care 2024: MICHAEL J. FRIEDLANDER

EXECUTIVE DIRECTOR, FRALIN BIOMEDICAL RESEARCH INSTITUTE AT VTC; VICE PRESIDENT FOR HEALTH SCIENCES AND TECHNOLOGY, VIRGINIA TECH, ROANOKE

//August 29, 2024//

Health Care 2024: MICHAEL J. FRIEDLANDER

EXECUTIVE DIRECTOR, FRALIN BIOMEDICAL RESEARCH INSTITUTE AT VTC; VICE PRESIDENT FOR HEALTH SCIENCES AND TECHNOLOGY, VIRGINIA TECH, ROANOKE

// August 29, 2024//

Listen to this article

As founder and head of the Fralin Biomedical Research Institute at VTC, Friedlander leads 40 research teams with more than 450 faculty, staff and students working together to solve major health challenges, including brain disorders, heart disease and cancer.

Under his leadership, the institute, which was founded in 2010, has been awarded more than $379 million in grants and contracts.

Last year, Red Gates Foundation, established by the estate of Richmond philanthropist Bill Goodwin’s late son, Hunter, made a $50 million commitment to support cancer and neuroscience research at the Fralin Institute.

In June, the Focused Ultrasound Foundation, a Charlottesville-based nonprofit that promotes the use of ultrasonic energy to target tissue deep in the body, designated Virginia Tech as a Focused Ultrasound Center of Excellence, making it the sixth such center in the United States and one of only 12 in the world. Friedlander will be the center’s chair.

A neuroscientist, Friedlander also leads academic programs for medical, doctoral, graduate and undergraduate students at Virginia Tech. 

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.